Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 106

Sort by

Sort Order Select

Journal Articles

ENO1 promotes Acute Myeloid Leukemia progression through SCD1-mediated lipid metabolism reprogramming

Yijun Wu, Shaoyan Hu, Li Gao, Fang Fang, Zhiheng Li, Yixin Hu, Yongping Zhang, Chenwei Yang, Zhongling Wei, Xin Liu, Yang Yang, Fenli Zhang, Weiliang Zhang, kaixuan Sun, Yizhen Li, Yang Chun, Jian Pan

Blood (2025) 146 (Supplement 1): 1471.

https://doi.org/10.1182/blood-2025-1471

Published: 2025

Journal Articles

An exploratory study to evaluate the safety and efficacy of autologous CAR-T cells with dual targeting of BCMA and CD19 (FKC289 Injection) in subjects with relapsed or refractory systemic light chain amyloidosis

Jing Li, Shiyang Gu, Yuhong Ren, Yang Yang, Jiadai Xu, Yian Zhang, Tianhong Xu, Xiaochen Wang, Xiaojiao Zhao, He Xin, Zisong Zhou, Peng Liu

Blood (2025) 146 (Supplement 1): 7674.

https://doi.org/10.1182/blood-2025-7674

Published: 2025

Journal Articles

Prognostic significance of 1q21 gain/amplification and co-existing cytogenetic abnormalities in Chinese patients with newly diagnosed multiple myeloma

Xinyuan Dai, YI LI, Gaofeng Zheng, Xiaoyan Han, Minlei Zhao, Yang Yang, Donghua He, Li Yang, Dan Cao, Lihong Shou, Linjie Li, Haowen Xiao, Wenjun Wu, Yi Zhao, Zhen Cai, Jingsong He

Blood (2025) 146 (Supplement 1): 2242.

https://doi.org/10.1182/blood-2025-2242

Published: 2025

Journal Articles

Characteristics of immune genes rearrangements in Chinese multiple myeloma patients

Donghua He, Yang Yang, Yiwei Zhou, Enfan Zhang, Li Yang, Xiaoyan Han, Jingsong He, Zhen Cai

Blood (2025) 146 (Supplement 1): 5759.

https://doi.org/10.1182/blood-2025-5759

Published: 2025

Journal Articles

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

Juan Peng, Zekai Mao, Yang Cao, Na Wang, Jue Wang, Yang Yang, Jinghuan Xu, Fankai Meng, Liting Chen, Xia Mao, Jiaqi Guo, Xiaoxi Zhou, Yicheng Zhang, Jia Wei

Blood (2025) 146 (Supplement 1): 3712.

https://doi.org/10.1182/blood-2025-3712

Published: 2025

Journal Articles

Survival prediction in relapsed/refractory B-cell lymphoma treated with CAR-T therapy: An AI-optimized cox regression model based on CCL5, scgf-β, and TRAIL

Hu Qian, Zekai Mao, Anqi Zhang, Xiaoying Zhang, Xingcheng Yang, Juan Peng, Jiaqi Guo, Liting Chen, Hui Luo, Li Zhu, Xiaoxi Zhou, Yang Yang, Na Wang, Jue Wang, Yicheng Zhang, Jia Wei

Blood (2025) 146 (Supplement 1): 4115.

https://doi.org/10.1182/blood-2025-4115

Published: 2025

Journal Articles

A single-center retrospective study of ixazomib-based regimens as maintenance therapy in newly diagnosed multiple myeloma

Yang Yang, Lin Luo, Zhongqing Li, Li Zhou, Rongrong Liu, Jun Luo

Blood (2025) 146 (Supplement 1): 7593.

https://doi.org/10.1182/blood-2025-7593

Published: 2025

Journal Articles

Targeted capture sequencing identifies driver mutations and enables prognostic modeling in multiple myeloma

Yang Yang, Donghua He, Jingsong He, Jie Zhang, Yang Nie, Ying Kong, He Huang, Zhen Cai

Blood (2025) 146 (Supplement 1): 5778.

https://doi.org/10.1182/blood-2025-5778

Published: 2025

Journal Articles

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Blood (2025) 145 (23): 2685–2700.

https://doi.org/10.1182/blood.2024027270

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting senescent stemlike subpopulations in Philadelphia chromosome–like acute lymphoblastic leukemia

Blood (2025) 145 (11): 1195–1210.

https://doi.org/10.1182/blood.2024026482

Published: 2025

Includes: Supplemental data

Journal Articles

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Mengmeng Dong, Xiao Xiao, Zhen Cai, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Li Yang, Haimeng Yan

Blood (2024) 144 (Supplement 1): 6894.

https://doi.org/10.1182/blood-2024-210534

Published: 2024

Journal Articles

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Qingxiao Chen, Jiasheng Wang, Yang Yang, Gaofeng Zheng, Jing Chen, Xiaoyan Han, Li Yang, Wenjun Wu, YI LI, Donghua He, Jingsong He, Zhen Cai

Blood (2024) 144 (Supplement 1): 7051.

https://doi.org/10.1182/blood-2024-197887

Published: 2024

Journal Articles

Study on the Molecular Genetic Characteristics of Multiple Myeloma Patients in China

Yang Yang, Jingsong He, Gaofeng Zheng, Xiaoyan Han, Yang Nie, Li Sun, Haoran Ma, Ying Wu, Jie Zhang, Zhen Cai

Blood (2024) 144 (Supplement 1): 6816.

https://doi.org/10.1182/blood-2024-202862

Published: 2024

Journal Articles

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Jing Li, Yang Yang, Chenqi Yu, Yuxia Yang, Peng Liu

Blood (2024) 144 (Supplement 1): 4700.

https://doi.org/10.1182/blood-2024-207188

Published: 2024

Journal Articles

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Yang Yang, Wenjing Wang, Liang Ren, Yawen Wang, Aziguli Maihemaiti, Tianwei Lan, Chi Zhou, Panpan Li, Pu Wang, Jing Li, Jiadai Xu, Tianhong Xu, Fei-fei Chen, Peng Liu

Blood (2024) 144 (Supplement 1): 6956.

https://doi.org/10.1182/blood-2024-207788

Published: 2024

Journal Articles

Survival of Hemodialysis-Dependent Multiple Myeloma Patients and Factors Associated with Dialysis Independence: A Real-World Study in China

Chenyun Wang, Jinuo Wang, Yang Yang, Donghua He, Gaofeng Zheng, Xiaoyan Han, Jingsong He, Jinping Ying, Wenjun Wu, Zhen Cai

Blood (2024) 144 (Supplement 1): 6913.

https://doi.org/10.1182/blood-2024-201472

Published: 2024

Journal Articles

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Blood (2024) 144 (Supplement 1): 5092.

https://doi.org/10.1182/blood-2024-198455

Published: 2024

Journal Articles

Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structure

Baixue Tang, Xinming Wang, Hanqing He, Ruiqing Chen, Guofeng Qiao, Yang Yang, Zihan Xu, Longteng Wang, Qiongye Dong, Jia Yu, Michael Q. Zhang, Minglei Shi, Jianwei Wang

Blood (2024) 143 (2): 124–138.

https://doi.org/10.1182/blood.2023020539

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

When Patients with Plasma Cell Disorders Encountered the Largest Omicron Wave (December 2022) in China: A Real-World Multicenter and Multiregional Study

Xincheng Jiang, Zhen Cai, Xiaoyan Han, Fengyan Jin, Gang An, Jian Hou, Jingsong He, Qingming Wang, Wenjun Wu, Yi Zhao, Songfu Jiang, Shuchan Li, Zhenshu Xu, Gaofeng Zheng, Yang Yang, Qingxiao Chen, Donghua He, Yi Li

Blood (2023) 142 (Supplement 1): 6673.

https://doi.org/10.1182/blood-2023-174224

Published: 2023

Journal Articles

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Tianhong Xu, Jing Li, Yang Yang, Wenjing Wang, Pu Wang, Chenqi Yu, Peng Liu

Blood (2023) 142 (Supplement 1): 6770.

https://doi.org/10.1182/blood-2023-184754

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

ENO1 promotes Acute Myeloid Leukemia progression through SCD1-mediated lipid metabolism reprogramming

An exploratory study to evaluate the safety and efficacy of autologous CAR-T cells with dual targeting of BCMA and CD19 (FKC289 Injection) in subjects with relapsed or refractory systemic light chain amyloidosis

Prognostic significance of 1q21 gain/amplification and co-existing cytogenetic abnormalities in Chinese patients with newly diagnosed multiple myeloma

Characteristics of immune genes rearrangements in Chinese multiple myeloma patients

Long-term follow-up reveals sustained benefit of dual CD19/CD22 CAR T-cell therapy alone or combined with autologous stem cell transplantation in TP53-altered relapsed/refractory B-cell non-Hodgkin lymphoma

Survival prediction in relapsed/refractory B-cell lymphoma treated with CAR-T therapy: An AI-optimized cox regression model based on CCL5, scgf-β, and TRAIL

A single-center retrospective study of ixazomib-based regimens as maintenance therapy in newly diagnosed multiple myeloma

Targeted capture sequencing identifies driver mutations and enables prognostic modeling in multiple myeloma

Single-cell panleukemia signatures of HSPC-like blasts predict drug response and clinical outcome

Targeting senescent stemlike subpopulations in Philadelphia chromosome–like acute lymphoblastic leukemia

Anomalous Peaks Observed in the Mass Spectrometry of Light Chains Correlate with the Diagnosis of AL Amyloidosis

Selinexor Combined with Daratumumab, Thalidomide, and Dexamethasone in Patients with First Relapsed Multiple Myeloma: A Single-Arm, Multicenter, Prospective Study

Study on the Molecular Genetic Characteristics of Multiple Myeloma Patients in China

Assessing Cytogenetic Abnormalities in Myeloma: A Comparative Study of Hi-C, Karyotyping, and iFISH Techniques

Double-Hit/Triple-Hit Myeloma: An Adverse Prognostic Factor That Can be Overcome By Minimal Residual Disease Negativity

Survival of Hemodialysis-Dependent Multiple Myeloma Patients and Factors Associated with Dialysis Independence: A Real-World Study in China

Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structure

When Patients with Plasma Cell Disorders Encountered the Largest Omicron Wave (December 2022) in China: A Real-World Multicenter and Multiregional Study

Clinical Implication of Minimal Residual Disease By Multiparameter Flow Cytometry in Light Chain Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only